Napsin A - Revision history

Michael: /* Positive */

2019-10-10T14:55:21Z

Positive

← Older revision		Revision as of 14:55, 10 October 2019
Line 4:		Line 4:
	*[[Lung adenocarcinoma]] - 83% of cases.<ref name=pmid19740516>{{Cite journal \| last1 = Bishop \| first1 = JA. \| last2 = Sharma \| first2 = R. \| last3 = Illei \| first3 = PB. \| title = Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. \| journal = Hum Pathol \| volume = 41 \| issue = 1 \| pages = 20-5 \| month = Jan \| year = 2010 \| doi = 10.1016/j.humpath.2009.06.014 \| PMID = 19740516 }}</ref>		*[[Lung adenocarcinoma]] - 83% of cases.<ref name=pmid19740516>{{Cite journal \| last1 = Bishop \| first1 = JA. \| last2 = Sharma \| first2 = R. \| last3 = Illei \| first3 = PB. \| title = Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. \| journal = Hum Pathol \| volume = 41 \| issue = 1 \| pages = 20-5 \| month = Jan \| year = 2010 \| doi = 10.1016/j.humpath.2009.06.014 \| PMID = 19740516 }}</ref>
	*[[Papillary renal cell carcinoma]] 79% of cases.<ref name=pmid19740516/>		*[[Papillary renal cell carcinoma]] 79% of cases.<ref name=pmid19740516/>
			*[[Renal oncocytoma]] 57% of cases.<ref name=pmid25889632>{{Cite journal \| last1 = Zhu \| first1 = B. \| last2 = Rohan \| first2 = SM. \| last3 = Lin \| first3 = X. \| title = Immunoexpression of napsin A in renal neoplasms. \| journal = Diagn Pathol \| volume = 10 \| issue = \| pages = 4 \| month = Mar \| year = 2015 \| doi = 10.1186/s13000-015-0242-z \| PMID = 25889632 }}</ref>
	===Occasionally positive===		===Occasionally positive===
	*[[Clear cell renal cell carcinoma]] - 34% of cases.<ref name=pmid19740516/>		*[[Clear cell renal cell carcinoma]] - 34% of cases.<ref name=pmid19740516/>
	*[[Papillary thyroid carcinoma]] - 2/81 cases, tall cell variant only.<ref name=pmid19740516/>		*[[Papillary thyroid carcinoma]] - 2/81 cases, tall cell variant only.<ref name=pmid19740516/>
			*[[Clear cell tubulopapillary RCC]] - 47% of cases.<ref name=pmid25889632/>

	==Negative==		==Negative==

Michael at 20:56, 5 May 2016

2016-05-05T20:56:09Z

← Older revision		Revision as of 20:56, 5 May 2016
Line 1:		Line 1:
	'''Napsin A''', also '''~~Napsin~~''', is a commonly used [[immunostain]] in [[pulmonary pathology]].		'''Napsin A''', also '''napsin''', is a commonly used [[immunostain]] in [[pulmonary pathology]].

	==Positive==		==Positive==

Jensflorian: + images

2015-10-08T13:28:24Z

+ images

← Older revision		Revision as of 13:28, 8 October 2015
Line 14:		Line 14:
	*[[Pancreatic adenocarcinoma]].<ref name=pmid19740516/>		*[[Pancreatic adenocarcinoma]].<ref name=pmid19740516/>
	*[[Breast carcinoma]] (0 positive of 17 cases<ref name=pmid19740516/>).		*[[Breast carcinoma]] (0 positive of 17 cases<ref name=pmid19740516/>).

			<gallery>
			File:Adenocarcinoma - Napsin A immunostain (6838767882).jpg \| Napsin in pulomonary adenocarcinoma (WC/Yale Rosen)
			File:Adenocarcinoma - Napsin A immunostain (5762462036).jpg \| Coarse Napsin staining pattern (WC/Yale Rosen)
			</gallery>

	==See also==		==See also==

Michael: /* Negative */

2015-10-05T14:02:16Z

Negative

← Older revision		Revision as of 14:02, 5 October 2015
Line 13:		Line 13:
	*[[Colorectal adenocarcinoma]].<ref name=pmid19740516/>		*[[Colorectal adenocarcinoma]].<ref name=pmid19740516/>
	*[[Pancreatic adenocarcinoma]].<ref name=pmid19740516/>		*[[Pancreatic adenocarcinoma]].<ref name=pmid19740516/>
	*[[Breast carcinoma]].<ref name=pmid19740516/>		*[[Breast carcinoma]] (0 positive of 17 cases<ref name=pmid19740516/>).

	==See also==		==See also==

Michael at 19:36, 9 September 2015

2015-09-09T19:36:37Z

← Older revision		Revision as of 19:36, 9 September 2015
Line 1:		Line 1:
	'''Napsin''' is a commonly used [[immunostain]] in [[pulmonary pathology]].		'''Napsin A''', also '''Napsin''', is a commonly used [[immunostain]] in [[pulmonary pathology]].

	==Positive==		==Positive==

Michael: Michael moved page Napsin to Napsin A: more formal

2015-09-09T19:36:22Z

Michael moved page Napsin to Napsin A: more formal

← Older revision

Revision as of 19:36, 9 September 2015

Michael: Created page with "'''Napsin''' is a commonly used immunostain in pulmonary pathology. ==Positive== *Lung adenocarcinoma - 83% of cases.{{Cite journal | last..."

2015-09-09T19:34:26Z

Created page with "'''Napsin''' is a commonly used immunostain in pulmonary pathology. ==Positive== *Lung adenocarcinoma - 83% of cases.<ref name=pmid19740516>{{Cite journal | last..."

New page

'''Napsin''' is a commonly used [[immunostain]] in [[pulmonary pathology]].

==Positive==
*[[Lung adenocarcinoma]] - 83% of cases.<ref name=pmid19740516>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Sharma | first2 = R. | last3 = Illei | first3 = PB. | title = Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. | journal = Hum Pathol | volume = 41 | issue = 1 | pages = 20-5 | month = Jan | year = 2010 | doi = 10.1016/j.humpath.2009.06.014 | PMID = 19740516 }}</ref>
*[[Papillary renal cell carcinoma]] 79% of cases.<ref name=pmid19740516/>

===Occasionally positive===
*[[Clear cell renal cell carcinoma]] - 34% of cases.<ref name=pmid19740516/>
*[[Papillary thyroid carcinoma]] - 2/81 cases, tall cell variant only.<ref name=pmid19740516/>

==Negative==
*[[Squamous cell carcinoma of the lung]].<ref name=pmid19740516/>
*[[Colorectal adenocarcinoma]].<ref name=pmid19740516/>
*[[Pancreatic adenocarcinoma]].<ref name=pmid19740516/>
*[[Breast carcinoma]].<ref name=pmid19740516/>

==See also==
*[[Immunohistochemistry]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]